Autopsy report · NCT01647412

Growth Hormone and Exclusion Diet Therapy in Juvenile Crohn's Disease

“PI left the institution”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Columbia University

Sponsor type

University, hospital or other

Conditions

Crohn's Disease

Interventions

Growth Hormone; Nutraceutical Combination; Exclusion Diet; Placebo Growth Hormone

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Concussion and Post Traumatic Stress in Traumatic Brain Injury
  “PI has left the institution.” (95% match in meaning)
• Arabin Pessary Combine With Vaginal Progesterone Compare With Vaginal Progesterone Alone to Prevent Preterm Delivery in Singleton Pregnancies
  “Former PI Left the Institution” (94% match in meaning)
• Erlotinib and Standard Platinum-Based Chemotherapy for Newly Diagnosed, Advanced Non-Small Cell Carcinoma of the Lung
  “PI left institution.” (93% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.